Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

31
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

45
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
45
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

39
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
39
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

423
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
423

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Dilated cardiomyopathy in a patient with Cushing's disease - clinical presentation, diagnosis and treatment: a case report].

Problemy endokrinologii·2025
Same author

Relationship Between the Biomarkers of Collagen Regulation and Echocardiography Parameters in Patients With Heart Failure With Preserved Ejection Fraction.

Kardiologiia·2025
Same author

Extended chains in vanadium O-centered complex [V<sub>4</sub>OSe<sub>8</sub>I<sub>5</sub>]<sub>∞</sub>: synthesis and structure.

Dalton transactions (Cambridge, England : 2003)·2024
Same author

The risk score for in-hospital mortality in patients with ST-segment elevation myocardial infarction.

Kardiologiia·2021
Same author

[Assessment of no-reflow phenomenon in patients with acute ST-elevation myocardial infarction].

Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery·2021
Same author

Influence of Total Ischemic Time on Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction.

Kardiologiia·2021
Same journal

[Clinical Case of Using Inclisiran in a Patient with End-Stage Renal Disease, Before and After Kidney Transplantation].

Kardiologiia·2026
Same journal

Cardiometabolic and Antioxidant Properties of Modified C-Terminal Fragments of Apelin in Experimental Cardiac Pathology.

Kardiologiia·2026
Same journal

Peroxisome Biogenesis Factor 10 Upregulation Promotes Cardiomyocyte Ferroptosis and Glutathione Peroxidase 4 Repression During Myocardial Ischemia-Reperfusion Injury.

Kardiologiia·2026
Same journal

Diagnostic Value and Prognostic Assessment of Exercise Stress Echocardiography in Patients With Suspected Coronary Artery Disease Without Typical Angina Symptoms.

Kardiologiia·2026
Same journal

Early Post-discharge Glycemic Control and Cardiovascular Event Readmission in Patients With Heart Failure and Type 2 Diabetes: A Single-center Retrospective Cohort Study.

Kardiologiia·2026
Same journal

Microcirculatory Features of the Conjunctiva and Retina in Patients with Stable Ischemic Heart Disease and Various Patterns of Coronary Artery Involvement.

Kardiologiia·2026
See all related articles

Related Experiment Video

Updated: Aug 31, 2025

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.1K

[Testosterone and congestive heart failure].

T N Enina1, V A Kuznetsov1, A M Soldatova1

  • 1Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Tomsk.

Kardiologiia
|August 22, 2022
PubMed
Summary
This summary is machine-generated.

Low testosterone is common in chronic heart failure (CHF). This review examines testosterone

More Related Videos

A Modified Technique for Transverse Aortic Constriction in Mice
04:52

A Modified Technique for Transverse Aortic Constriction in Mice

Published on: August 18, 2022

4.8K
Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
10:18

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model

Published on: June 29, 2014

17.2K

Related Experiment Videos

Last Updated: Aug 31, 2025

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.1K
A Modified Technique for Transverse Aortic Constriction in Mice
04:52

A Modified Technique for Transverse Aortic Constriction in Mice

Published on: August 18, 2022

4.8K
Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
10:18

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model

Published on: June 29, 2014

17.2K

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Chronic heart failure (CHF) is a complex condition with various contributing factors.
  • Testosterone plays a role in cardiovascular health, and its deficiency is increasingly recognized in specific patient populations.

Purpose of the Study:

  • To review the current literature on the relationship between testosterone levels and chronic heart failure.
  • To explore the impact of testosterone on the cardiovascular system and its relevance in CHF patients.

Main Methods:

  • Systematic review of key publications.
  • Analysis of studies investigating testosterone deficiency prevalence in CHF.
  • Examination of research on testosterone's cardiovascular effects.
  • Evaluation of the link between testosterone levels and CHF severity/prognosis.
  • Assessment of interventional treatment efficacy for CHF in relation to testosterone.

Main Results:

  • Testosterone deficiency is prevalent in patients with chronic heart failure.
  • Endogenous and exogenous testosterone have significant effects on the cardiovascular system.
  • Lower testosterone levels correlate with increased CHF severity and poorer prognosis.
  • Interventional treatments for CHF may be influenced by testosterone status.

Conclusions:

  • The interrelation between testosterone and chronic heart failure is significant.
  • Monitoring and potentially treating testosterone deficiency may be important in managing CHF patients.
  • Further research is warranted to elucidate optimal therapeutic strategies.